These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26595972)

  • 21. 340B program presents opportunities--and challenges.
    Keough CL; Webster SA
    Healthc Financ Manage; 2009 Nov; 63(11):42-4, 46, 48. PubMed ID: 19891397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-18. PubMed ID: 20213921
    [No Abstract]   [Full Text] [Related]  

  • 23. American pharmaceutical prices.
    Alagona P
    Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(4):58. PubMed ID: 12592980
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
    [No Abstract]   [Full Text] [Related]  

  • 26. Healthcare reform and expenditure on drugs. The German situation.
    Ulrich V; Wille E
    Pharmacoeconomics; 1996; 10 Suppl 2():81-8. PubMed ID: 10163440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Canadians are killing us.
    Struble RA
    Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(4):58-9. PubMed ID: 12592981
    [No Abstract]   [Full Text] [Related]  

  • 28. Providers offer prescription for Medicaid drug-pricing law.
    Chaconas J
    Trustee; 1991 Dec; 44(12):12, 19. PubMed ID: 10115321
    [No Abstract]   [Full Text] [Related]  

  • 29. Think royalties, not caps.
    Nat Biotechnol; 1998 Jul; 16(7):595. PubMed ID: 9661166
    [No Abstract]   [Full Text] [Related]  

  • 30. Early benefit assessment for pharmaceuticals in Germany: lessons for policymakers.
    Schlette S; Hess R
    Issue Brief (Commonw Fund); 2013 Oct; 29():1-9. PubMed ID: 24171232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs.
    Mello MM; Studdert DM; Brennan TA
    N Engl J Med; 2004 Feb; 350(6):608-13. PubMed ID: 14762190
    [No Abstract]   [Full Text] [Related]  

  • 32. Controlling the cost of prescription drugs.
    White JR
    Health Prog; 1992 Mar; 73(2):12-4, 25. PubMed ID: 10116498
    [No Abstract]   [Full Text] [Related]  

  • 33. State Remedies For Costly Prescription Drugs.
    Cauchi R
    NCSL Legisbrief; 2018 Aug; 26(29):1-2. PubMed ID: 30199170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the rise in American pharmaceutical prices.
    Marwaha A
    Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(2):11-5. PubMed ID: 12099112
    [No Abstract]   [Full Text] [Related]  

  • 35. Keep 340B savings where they belong--with patients and communities.
    Siegel B
    Mod Healthc; 2015 Mar; 45(9):25. PubMed ID: 25980203
    [No Abstract]   [Full Text] [Related]  

  • 36. The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.
    Werling K; Abraham S; Strelec J
    J Health Care Finance; 2007; 34(2):57-70. PubMed ID: 18972994
    [No Abstract]   [Full Text] [Related]  

  • 37. Importing Prescription Drugs from Canada - Legal and Practical Problems with the Trump Administration's Proposal.
    Sachs RE; Bagley N
    N Engl J Med; 2020 May; 382(19):1777-1779. PubMed ID: 32374960
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmaceuticals and medical devices: cost savings. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-33. PubMed ID: 23297446
    [No Abstract]   [Full Text] [Related]  

  • 39. Optimizing 340B purchasing practices.
    Almeter PJ; Johnson GL; Saenz R
    Am J Health Syst Pharm; 2012 Aug; 69(16):1366-8, 1370-1. PubMed ID: 22855101
    [No Abstract]   [Full Text] [Related]  

  • 40. Lowering the cost of prescription drugs.
    Jindal B
    J La State Med Soc; 2003; 155(1):51. PubMed ID: 12656276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.